Drug giant Allergan — famous for Botox — will be shuttering its Goleta facility and axing 1,500 of its 11,600 positions system-wide, the company announced Monday. Some of the 300 Goleta employees will be transferred to Irvine headquarters, said spokesperson Bonnie Jacobs. Jacobs declined to comment on when the closure and layoffs will take place. Allergan outlined its decision in its second-quarter operating report, which noted “the strongest increase in absolute dollar sales in any quarter in our history” but cited an ongoing buyout battle with Valeant Pharmaceuticals International, Inc. The cuts will save Allergan up to $425 million next year.
